These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35234441)

  • 41. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction and Biological Evaluation of a Novel Integrin α
    Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
    Kong L; Wu Y; Alves CS; Shi X
    Nanomedicine (Lond); 2016 Dec; 11(23):3103-3115. PubMed ID: 27809656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendrimer-Stabilized Gold Nanostars as a Multifunctional Theranostic Nanoplatform for CT Imaging, Photothermal Therapy, and Gene Silencing of Tumors.
    Wei P; Chen J; Hu Y; Li X; Wang H; Shen M; Shi X
    Adv Healthc Mater; 2016 Dec; 5(24):3203-3213. PubMed ID: 27901317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.
    Kara G; Parlar A; Cakmak MC; Cokol M; Denkbas EB; Bakan F
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111340. PubMed ID: 32956996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
    Sarkhosh-Inanlou R; Imani M; Sam MR
    Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral siRNA delivery using dual transporting systems to efficiently treat colorectal liver metastasis.
    Hyun EJ; Hasan MN; Kang SH; Cho S; Lee YK
    Int J Pharm; 2019 Jan; 555():250-258. PubMed ID: 30399434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
    Lu ZX; Liu LT; Qi XR
    Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma.
    Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F
    Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Albumin-stabilized manganese-based nanocomposites with sensitive tumor microenvironment responsivity and their application for efficient SiRNA delivery in brain tumors.
    Xu K; Zhao Z; Zhang J; Xue W; Tong H; Liu H; Zhang W
    J Mater Chem B; 2020 Feb; 8(7):1507-1515. PubMed ID: 32003397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy.
    Rengaswamy V; Zimmer D; Süss R; Rössler J
    J Control Release; 2016 Aug; 235():319-327. PubMed ID: 27261335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism.
    Ren Y; Yuan B; Hou S; Sui Y; Yang T; Lv M; Zhou Y; Yu H; Li S; Peng H; Chang N; Liu Y
    J Drug Target; 2021 Sep; 29(8):863-874. PubMed ID: 33507113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amelioration of colorectal cancer using negative lipidoid nanoparticles to encapsulate siRNA against APRIL by enema delivery mode.
    Ding W; Wang G; Shao K; Wang F; Huang H; Ju S; Cong H; Wang H
    Pathol Oncol Res; 2014 Oct; 20(4):953-64. PubMed ID: 24771268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].
    Sakurai Y
    Yakugaku Zasshi; 2019; 139(11):1357-1363. PubMed ID: 31685731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
    Wei W; Lv PP; Chen XM; Yue ZG; Fu Q; Liu SY; Yue H; Ma GH
    Biomaterials; 2013 May; 34(15):3912-23. PubMed ID: 23453062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
    Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
    Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.